Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Pro

Ophthalmology Bala Cynwyd, PA Medical Doctor

NPI 1639137524 CMS profile 255227

100 Presidential Blvd Ste 200, Bala Cynwyd, PA 19004

Open in the dashboard

General payments

$35,272

147 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Pro of Bala Cynwyd, PA is reported in the CMS Open Payments database as having received $35,272 across 147 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15,243 31
2024 General $13,277 24
2023 General $1,278 22
2022 General $579 11
2021 General $282 10
2020 General $1,457 18
2019 General $3,157 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Pro
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Michael Pro were reported at $15,243. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Michael Pro Ophthalmology median Middle half National median
2019 $3,157 $258 $104–$655 $163
2020 $1,457 $126 $45–$321 $114
2021 $282 $205 $76–$534 $132
2022 $579 $266 $100–$678 $149
2023 $1,278 $308 $117–$745 $160
2024 $13,277 $340 $127–$846 $164
2025 $15,243 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. New World Medical,Inc. $18,732 23 payments
  2. Alcon Vision LLC $12,094 28 payments
  3. Glaukos Corporation $1,503 14 payments
  4. Sight Sciences, Inc. $1,417 23 payments
  5. Allergan Inc. $348 12 payments
  6. AbbVie, Inc. $286 12 payments
  7. Ivantis, Inc $258 2 payments
  8. Novartis Pharmaceuticals Corporation $206 14 payments
  9. Aerie Pharmaceuticals, Inc. $109 6 payments
  10. EllexiScience $106 1 payment
  11. Other $212 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $15,000 5 payments
  2. Consulting Fee $12,325 5 payments
  3. Food and Beverage $6,502 129 payments
  4. Travel and Lodging $1,302 4 payments
  5. Education $80 2 payments
  6. Gift $62 2 payments
Products named General payments · program years 2019–2025
  1. Ahmed Glaucoma Valve $18,463 19 payments
  2. Kahook Dual Blade $18,463 19 payments
  3. Clearpath $15,124 12 payments
  4. Streamline $15,124 12 payments
  5. Via360 $13,901 10 payments
  6. HYDRUS Microstent $10,646 13 payments
  7. OMNI SURGICAL SYSTEM $865 11 payments
  8. iDoseTR $354 2 payments
  9. iStent inject Trabecular Micro-Bypass Stent System $343 4 payments
  10. OMNI $284 6 payments
  11. Other $3,198 96 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

147 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record